Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
3.690
+0.050 (1.37%)
At close: May 1, 2026, 4:00 PM EDT
3.738
+0.048 (1.29%)
After-hours: May 1, 2026, 7:54 PM EDT
Eledon Pharmaceuticals Market Cap
Eledon Pharmaceuticals has a market cap or net worth of $280.32 million as of May 1, 2026. Its market cap has increased by 56.04% in one year.
Market Cap
280.32M
Enterprise Value
147.62M
1-Year Change
56.04%
Ranking
Category
Stock Price
$3.69
Market Cap Chart
Since May 11, 2017, Eledon Pharmaceuticals's market cap has increased from $44.66M to $280.32M, an increase of 527.67%. That is a compound annual growth rate of 22.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 280.32M | 147.03% |
| Dec 31, 2025 | 113.47M | -53.90% |
| Dec 31, 2024 | 246.13M | 465.07% |
| Dec 29, 2023 | 43.56M | 38.87% |
| Dec 30, 2022 | 31.37M | -50.29% |
| Dec 31, 2021 | 63.09M | -72.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zentalis Pharmaceuticals | 290.11M |
| Protara Therapeutics | 287.73M |
| C4 Therapeutics | 284.93M |
| Editas Medicine | 283.83M |
| Cellectis | 283.24M |
| Foghorn Therapeutics | 279.41M |
| LENZ Therapeutics | 278.43M |
| Coherus Oncology | 277.59M |